Biotech Values

[JJM760]

He can say whatever he wants (and he sure had a lot to say yesterday), but for Ariad to "win", Iclusig clearly has to do well into the 50's. There must be a definitive difference between Iclusig and Tasigna/Sprycel for that switch market (2 bil+) as well.

Berger/Ariad have a history of not meeting timelines and setting up Ariad stock for failure. He did it again yesterday with his comments about EGFR T790 data at ESMO. Those of us who follow the company have seen them miss self established deadlines before and pay the price.

The street essentially just gave 113 no value in T790 and has declared CLVS the winner by virtue of its 2 bil+ MC. Why not STFU and catch everyone sleeping at ESMO instead of setting up for another data deadline miss(or perhaps worse a disappointing data set).

This company is looking very good at this point. If Iclusig 12 month MMR is somewhere over 55%, he won't have to say a word. Let your product do the talking. I'm starting to sound like friggin Dew now. Sheesh!

BTW, this is all just a rehashed Don Shimoda rant.